Skip to content

Drug interactions

Rasagiline + Somatropin

Severity: Minor

Rasagiline and Somatropin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Growth hormone may increase the activity of some cytochrome P450 enzymes, which could speed the clearance of CYP1A2 substrates such as rasagiline. This could lower rasagiline exposure and reduce its effect on motor symptoms. Evidence is limited and the clinical significance is uncertain.

What this interaction means in plain words

Rasagiline and Somatropin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Rasagiline belongs to Central Nervous System; Somatropin belongs to Endocrine.

Evidence level: Low

Why it happens

Somatropin may induce CYP450 activity including CYP1A2, increasing hepatic clearance of rasagiline.

What to do

Watch for loss of motor control in Parkinson's patients starting or stopping somatropin. Adjust the rasagiline dose only if symptoms worsen.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rasagiline and Somatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rasagiline with Somatropin?

MediHelp rates the interaction as minor. Rasagiline and Somatropin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Growth hormone may increase the activity of some cytochrome P450 enzymes, which could speed the clearance of CYP1A2 substrates such as rasagiline. This could lower rasagiline exposure and reduce its effect on motor symptoms. Evidence is limited and the clinical significance is uncertain.

How serious is the interaction between Rasagiline and Somatropin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Watch for loss of motor control in Parkinson's patients starting or stopping somatropin. Adjust the rasagiline dose only if symptoms worsen.

What other medicines interact with Rasagiline?

MediHelp also lists interactions of Rasagiline with, for example, Atomoxetine, Brimonidine, Bupropion-naltrexone. The full list is on the Rasagiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in